Close Menu

cervical cancer

Oncgnostics also expects the test to be approved by regulators in Canada and to be sold there by the end of the year.

Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.

The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.

The German biotech firm said its lateral flow blood test does not detect subclinical HPV infection but picks up on HPV-induced cancers and pre-cancers.

Hologic designed its scalable AI-based cytology platform to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.

Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.

The supplement adds a collection vial to the BD Onclarity test and includes performance data for the BD Viper LT and the BD COR Systems.

The test detects the presence of two biomarkers within a single cell associated with HPV infections that can progress to cervical cancer.

The expanded test can be used for genotype risk-based patient monitoring to prevent over-treatment, BD has said.

The researchers are developing an automated machine-learning approach to analyze the expression of protein markers associated with cervical cancer.

Pages